Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Lilly(Eli) & Co (NYSE: LLY) closed the day trading at $684.43 up 3.62% from the previous closing price of $660.49. In other words, the price has increased by $3.62 from its previous closing price. On the day, 8.33 million shares were traded. LLY stock price reached its highest trading level at $685.41 during the session, while it also had its lowest trading level at $655.1.
Ratios:
For a better understanding of LLY, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 182.68 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 132.61. For the most recent quarter (mrq), Quick Ratio is recorded 1.00 and its Current Ratio is at 1.28. In the meantime, Its Debt-to-Equity ratio is 2.18 whereas as Long-Term Debt/Eq ratio is at 1.87.
HSBC Securities Downgraded its Buy to Reduce on April 28, 2025, whereas the target price for the stock was revised from $1150 to $700.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 13 ’25 when Alvarez Ralph bought 758 shares for $660.25 per share. The transaction valued at 500,473 led to the insider holds 758 shares of the business.
Van Naarden Jacob bought 1,000 shares of LLY for $647,360 on Aug 13 ’25. The EVP & Pres., Lilly Oncology now owns 20,562 shares after completing the transaction at $647.36 per share. On Aug 12 ’25, another insider, Ricks David A, who serves as the President, Chair, and CEO of the company, bought 1,632 shares for $644.77 each. As a result, the insider paid 1,052,263 and bolstered with 546,601 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LLY now has a Market Capitalization of 613562056704 and an Enterprise Value of 650948444160. As of this moment, Lilly(Eli)’s Price-to-Earnings (P/E) ratio for their current fiscal year is 45.38, and their Forward P/E ratio for the next fiscal year is 22.56. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.07. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.16 while its Price-to-Book (P/B) ratio in mrq is 35.46. Its current Enterprise Value per Revenue stands at 12.223 whereas that against EBITDA is 26.274.
Stock Price History:
The Beta on a monthly basis for LLY is 0.46, which has changed by -0.2577647 over the last 52 weeks, in comparison to a change of 0.16461086 over the same period for the S&P500. Over the past 52 weeks, LLY has reached a high of $972.53, while it has fallen to a 52-week low of $623.78. The 50-Day Moving Average of the stock is -10.57%, while the 200-Day Moving Average is calculated to be -13.84%.
Shares Statistics:
Over the past 3-months, LLY traded about 4.28M shares per day on average, while over the past 10 days, LLY traded about 8966100 shares per day. A total of 946.83M shares are outstanding, with a floating share count of 848.60M. Insiders hold about 10.34% of the company’s shares, while institutions hold 73.77% stake in the company. Shares short for LLY as of 1753920000 were 7172654 with a Short Ratio of 1.68, compared to 1751241600 on 7714191. Therefore, it implies a Short% of Shares Outstanding of 7172654 and a Short% of Float of 0.8999999999999999.
Dividends & Splits
LLY’s forward annual dividend rate is 5.60, up from 5.6 a year ago. Against a Trailing Annual Dividend Yield of 0.008478554The stock’s 5-year Average Dividend Yield is 1.08. The current Payout Ratio is 44.39% for LLY, which recently paid a dividend on 2025-05-16 with an ex-dividend date of 2025-08-15. Stock splits for the company last occurred on 1997-10-16 when the company split stock in a 2:1 ratio.
